VP Clinical Pharmacology – Neurology Biotech
US East Coast
We’re partnering with a recently funded, clinical-stage neurology biotech entering a pivotal phase of its growth.
With a clear roadmap toward US approval, this is a rare opportunity to join at a true inflection point and take a leading role in driving the NDA submission.
Why this opportunity stands out
- Recently funded biotech with strong financial backing and momentum
- Late-stage clinical program approaching key regulatory milestones
- Direct ownership of NDA-enabling workstreams
- High visibility with leadership and cross-functional teams
- Opportunity to shape both strategy and execution in a lean, expert environment
The role
You will act as the clinical pharmacology lead, owning both strategy and execution across regulatory deliverables.
Key responsibilities include:
- Leading clinical pharmacology strategy and NDA/MAA submission activities
- Acting as SME across PK/PD, metabolism, DDI, and special populations
- Interpreting and integrating preclinical and clinical pharmacology data
- Supporting global regulatory interactions and responses
- Collaborating cross-functionally across clinical and preclinical teams
What we’re looking for
- MD or PhD in Clinical Pharmacology (or related discipline)
- Strong experience in clinical pharmacology within biotech/pharma
- Proven track record contributing to IND/CTA and NDA/MAA submissions
- Expertise in PK/PD, ADME, and DDI
- Experience working directly with regulatory authorities
- Comfortable operating in a dynamic, fast-paced biotech setting
Why apply?
This is a high-impact role where you will:
- Lead a critical NDA submission from the front
- Influence regulatory strategy at a company-defining moment
- Work within a high-calibre, collaborative team
- Play a key role in bringing a novel neurology therapy closer to patients